[1] |
Xiaohui Li, Qian Wang, Chennan Liu, Jiangxue Han, Sihan Liu, Tianjun Liu, Qian Wang, Yan Guan, Chunling Xiao, Xiao Wang, Yishuang Liu.
PHT427 functions as a novel inhibitor of KPC-2
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(12): 989-997.
|
[2] |
Qian Wang, Chennan Liu, Jiangxue Han, Sihan Liu, Chunling Xiao, Yan Guan, Xinghua Li, Ying Wang, Xiao Wang, Jianzhou Meng, Maoluo Gan, Yishuang Liu.
(–)-Epicatechin gallate serves as a novel new delhi metallo-β-lactamase-1 (NDM-1) inhibitor
[J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(9): 716-724.
|
[3] |
Jing Zhou, Hong Zhang, Xiaojiao Li, Xiangshi Song, Mengmeng Zhang, Yanhua Ding.
Analysis of the effect of HCV resistance-associated substitutions on the short-term efficacy of DAA after single administration in three phase Ib clinical trials
[J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(2): 133-145.
|
[4] |
Yue Zhou, Haishaerjiang Wushouer, Xi Zhang, Jiajia Feng, Likai Lin, Bo Zheng, Xiaodong Guan, Luwen Shi.
Antimicrobial stewardship program in China’s tertiary hospitals in 2018: a nationwide cross-sectional online survey
[J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(12): 994-1007.
|
[5] |
Xixi Li, Qian Liu, Tao Sheng, Junyi Liu, Xiaowei Wang.
Pyridin-2(1H)-ones as HIV-1 NNRTIs: a combinatorial optimization strategy
[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(2): 79-89.
|
[6] |
Jiangxue Han, Chunling Xiao, Maoluo Gan, Xinghua Li, Ying Wang, Jiayin Zheng, Dongsheng Li, Chennan Liu, Yan Guan, Jianzhou Meng, Shuchao Huang, Yishuang Liu.
IMB-XH1 identified as a novel inhibitor of New Delhi metallo-β-lactamase-1
[J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(4): 238-246.
|
[7] |
Dongbo Lu, Yu Chen, Shan Liu, Chao Guo, Xia Li, Zhongjun Li, Xiangbao Meng.
Synthesis and biological evaluation of indeno[1, 2-b]indole derivatives as dual topoisomerase I & II inhibitors: novel multidrug resistant reversal anticancer agents
[J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(11): 786-801.
|
[8] |
Yuan Liu, Ya Chen, Jianxing Hu, Zhenming Liu, Liangren Zhang.
In silico pharmacophore models to predict endogenous substrates for human multidrug resistance-associated proteins
[J]. Journal of Chinese Pharmaceutical Sciences, 2017, 26(8): 545-555.
|
[9] |
Mohammad Asif.
Newly developed drugs invented to treat tuberculosis in clinical trial
[J]. Journal of Chinese Pharmaceutical Sciences, 2017, 26(1): 1-22.
|
[10] |
Yishuang Liu, Ying Wang, Jiayin Zheng, Xinghua Li, Yan Guan, Shuchao Huang, Chunling Xiao.
KL-0153, a novel inhibitor of Pseudomonas aeruginosa MexAB-OprM efflux pump
[J]. Journal of Chinese Pharmaceutical Sciences, 2016, 25(4): 310-315.
|
[11] |
Finna Setiawan, Elin Yulinah Sukandar, Sukrasno, Ketut Adnyana I.
Activity of tamarindus indica pulp water extract in high carbohydrate diet rats as a treatment for obesity and insulin resistance
[J]. Journal of Chinese Pharmaceutical Sciences, 2016, 25(12): 892-897.
|
[12] |
Aiting Wang, Shuwen Tong, Xin Hu, Xianrong Qi.
Preparation and anti-MDR tumors study of folate and TPGS dual-modified DSPE-PEG micelles loaded with docetaxel
[J]. Journal of Chinese Pharmaceutical Sciences, 2015, 24(7): 419-426.
|
[13] |
Tingting Li, Zhijun Wang, Haiyan Liu, Huiru Xie, Xuehua Jiang, Ling Wang.
Reversal of multidrug resistance in cancer treatment by regulating multidrug resistance gene1: focus on nuclear receptors and epigenetics
[J]. Journal of Chinese Pharmaceutical Sciences, 2015, 24(5): 273-284.
|
[14] |
Wenting Wu, Zhiyu Guan.
Docetaxel-loaded mixed micelles composed of Solutol HS15 and Pluronic F127 or folate-conjugated F127: preparation, optimization and in vitro comparative characterization
[J]. Journal of Chinese Pharmaceutical Sciences, 2015, 24(2): 95-103.
|
[15] |
Cunbao Liu, Weiwei Huang, Xu Yang, Yufeng Yao, Wenjia Sun, Yanbing Ma.
Silver nitrate restores susceptibility of clinical multidrug resistant gram-negative and gram-positive bacteria to amikacin in vitro
[J]. Journal of Chinese Pharmaceutical Sciences, 2014, 23(7): 500-503.
|